You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

List of Excipients in API etodolac


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing etodolac

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA, Inc. etodolac 0093-1122 ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Teva Pharmaceuticals USA, Inc. etodolac 0093-1122 CARBOMER 934
Teva Pharmaceuticals USA, Inc. etodolac 0093-1122 D&C YELLOW NO. 10 ALUMINUM LAKE
Teva Pharmaceuticals USA, Inc. etodolac 0093-1122 FD&C RED NO. 40
Teva Pharmaceuticals USA, Inc. etodolac 0093-1122 FD&C YELLOW NO. 6
Teva Pharmaceuticals USA, Inc. etodolac 0093-1122 HYDROXYPROPYL CELLULOSE
Teva Pharmaceuticals USA, Inc. etodolac 0093-1122 HYPROMELLOSE 2208
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for etodolac

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CARBOMER 934

Excipient focus: CARBOMER HOMOPOLYMER TYPE B

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 77491

Excipient focus: CI 77492

Excipient focus: CI 77891

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 28

Excipient focus: D&C RED NO. 33

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: ETHYLCELLULOSE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

etodolac drug variants containing FERRIC OXIDE RED

Company Ingredient NDC
Blenheim Pharmacal, Inc. etodolac 10544-862
Rebel Distributors Corp etodolac 21695-050
Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC etodolac 35356-711
Edenbridge Pharmaceuticals LLC etodolac 42799-111
A-S Medication Solutions etodolac 50090-3963
A-S Medication Solutions etodolac 50090-4053
Northwind Pharmaceuticals LLC etodolac 51655-423
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: FERRIC OXIDE YELLOW

etodolac drug variants containing FERRIC OXIDE YELLOW

Company Ingredient NDC
Blenheim Pharmacal, Inc. etodolac 10544-862
NORTHSTAR RX LLC etodolac 16714-498
Rebel Distributors Corp etodolac 21695-050
Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC etodolac 35356-711
Edenbridge Pharmaceuticals LLC etodolac 42799-111
A-S Medication Solutions etodolac 50090-3963
A-S Medication Solutions etodolac 50090-4053
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCINE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL METHYLCELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

etodolac drug variants containing HYPROMELLOSES

Company Ingredient NDC
Blenheim Pharmacal, Inc. etodolac 10544-862
Aidarex Pharmaceuticals LLC etodolac 33261-043
Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC etodolac 35356-711
Rebel Distributors Corp etodolac 42254-052
STAT Rx USA LLC etodolac 42549-511
Edenbridge Pharmaceuticals LLC etodolac 42799-111
Northwind Pharmaceuticals LLC etodolac 51655-423
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: INDIGOTINDISULFONATE SODIUM

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHYLCELLULOSE

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 1500

Excipient focus: POLYETHYLENE GLYCOL 1600

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE

Excipient focus: POVIDONE K25

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PVP

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN

etodolac drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN

Company Ingredient NDC
A-S Medication Solutions etodolac 50090-3963
A-S Medication Solutions etodolac 50090-3974
A-S Medication Solutions etodolac 50090-4053
Northwind Pharmaceuticals LLC etodolac 51655-423
Northwind Pharmaceuticals etodolac 51655-735
Preferred Pharmaceuticals Inc etodolac 68788-7300
Preferred Pharmaceuticals Inc etodolac 68788-7315
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

etodolac drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
Eon Labs Inc etodolac 0185-0140
Eon Labs Inc etodolac 0185-0675
Blenheim Pharmacal, Inc. etodolac 10544-862
Rebel Distributors Corp etodolac 21695-049
Rebel Distributors Corp etodolac 21695-050
Aidarex Pharmaceuticals LLC etodolac 33261-043
Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC etodolac 35356-711
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: STEARIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links